Single Increasing Doses of BIII 890 CL in Healthy Young Male Volunteers and in Healthy Elderly Male and Female Volunteers
NCT02269215
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
73
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
BIII 890 CL
DRUG:
Placebo
Sponsor
Boehringer Ingelheim